dTpa vaccine

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Diphtheria-Tetanus-acellular Pertussis VaccinesRespiratory Syncytial Virus Infections

Phase 3

A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age

CompletedNCT05169905

GlaxoSmithKlineRespiratory Syncytial Virus Infections

Start: 2022-02-02End: 2022-08-03Updated: 2023-04-07

A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

CompletedNCT07596173

GlaxoSmithKlineDiphtheria-Tetanus-acellular Pertussis Vaccines

Start: 2026-06-29End: 2026-09-04Updated: 2026-09-09